GMOEX
Price
$23.42
Change
+$0.17 (+0.73%)
Updated
Jan 17 closing price
Net Assets
N/A
VEMAX
Price
$36.46
Change
+$0.23 (+0.63%)
Updated
Jan 17 closing price
Net Assets
108.96B
Ad is loading...

GMOEX vs VEMAX

Header iconGMOEX vs VEMAX Comparison
Open Charts GMOEX vs VEMAXBanner chart's image
GMO Emerging Markets III
Price$23.42
Change+$0.17 (+0.73%)
VolumeN/A
Net AssetsN/A
Vanguard Emerging Mkts Stock Idx Adm
Price$36.46
Change+$0.23 (+0.63%)
VolumeN/A
Net Assets108.96B
GMOEX vs VEMAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GMOEX vs. VEMAX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GMOEX is a Buy and VEMAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
GMOEX pays higher dividends than VEMAX: GMOEX (5.88) vs VEMAX (3.43). GMOEX was incepted earlier than VEMAX: GMOEX (31 years) vs VEMAX (19 years). GMOEX is a more actively managed with annual turnover of: 128.00 vs. VEMAX (5.00). GMOEX has a lower initial minimum investment than VEMAX: GMOEX (0) vs VEMAX (3000). VEMAX annual gain was more profitable for investors over the last year : 13.87 vs. GMOEX (7.42). VEMAX return over 5 years is better than : 5.79 vs. GMOEX (-16.12).
GMOEXVEMAXGMOEX / VEMAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence31 years19 years-
Gain YTD-0.298-0.84335%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net AssetsN/A109B-
Annual Yield % from dividends5.883.43172%
Returns for 1 year7.4213.8754%
Returns for 3 years-19.16-5.30361%
Returns for 5 years-16.125.79-278%
Returns for 10 years17.8929.3461%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DC2.280.01
+0.44%
Dakota Gold Corp
TIGO27.01N/A
N/A
Millicom International Cellular SA
LUV32.10-0.06
-0.19%
Southwest Airlines Co
GSM4.07-0.01
-0.25%
Ferroglobe PLC
CARM0.44-0.02
-3.46%
Carisma Therapeutics